Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Chronic Kidney Disease: Prevention & Risk Reduction: Managing Blood Pressure & Blood Sugar, Avoiding Nephrotoxic Medications, Hydration, and Vascular Protection

A nephrology prevention reference on blood pressure and glycemic control, avoiding NSAIDs, hydration, smoking cessation and weight, with urine albumin and eGFR screening for early detection.

Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026

Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.

What we found that needs correcting

  • This brief identifies the right targets. Blood pressure, blood sugar, NSAID avoidance and urine albumin screening are the four things that prevent most preventable kidney disease, and putting the urine test alongside eGFR rather than after it is correct and frequently got wrong. The notes below add the numbers and qualify one claim.
  • The hydration section overstates what water does. Adequate fluid intake reduces kidney stones and protects against acute injury during illness and heat, which the brief says correctly. But there is no good evidence that drinking beyond thirst prevents or slows chronic kidney disease, and a randomised trial of increased water intake in people with CKD did not slow the decline in kidney function. Excessive intake can also cause dangerously low sodium, particularly in older adults. The accurate version is to drink to thirst and to drink more when ill, hot, or losing fluid.
  • A further point the brief should make: in advanced CKD, fluid usually has to be restricted rather than increased. A reader at stage 4 following the instruction to drink plenty of water could come to harm, and the brief carries no stage qualifier anywhere.
  • Target numbers would make the blood pressure section actionable. A target below 130/80 is common in people at kidney risk, and lower where albumin is leaking. Sodium under 2,300 mg a day is the usual figure. ACE inhibitors and ARBs are specifically preferred where there is diabetes or albuminuria, because they lower pressure inside the glomerulus as well as in the arteries.
  • The glycemic section predates the last decade of evidence. SGLT2 inhibitors slow progression of kidney disease in people with and without diabetes, and finerenone reduces progression in CKD with type 2 diabetes. These are now central to kidney protection and are not mentioned.
  • The NSAID section is correct but would be more useful with the specifics. The dangerous combination is an ACE inhibitor or ARB plus a diuretic plus an NSAID, which is a recognised cause of acute kidney injury. Paracetamol or acetaminophen is the preferred alternative, and topical NSAID gels deliver far less drug systemically.
  • Acute kidney injury is missing entirely, and it belongs in a prevention document. Each episode raises the risk of later CKD, many episodes are preventable with fluids and by temporarily pausing certain medicines during illness, and kidney function after an episode is frequently never rechecked. Written sick-day rules are the practical form of this advice.
  • Urinary obstruction is also absent. An enlarged prostate, stones or a narrowed ureter can cause progressive and reversible kidney damage, which is why an ultrasound is part of the assessment.
  • The screening section should say who to test and how often: annually for people with diabetes, high blood pressure, cardiovascular disease, a family history of kidney failure, or a previous acute kidney injury. Current United States guidance does not recommend screening the general population without risk factors, which is a statement about the evidence rather than about the value of the tests.
  • Everything else is accurate: hypertension damaging small renal vessels and reducing filtering capacity; chronic high glucose damaging the filtration barrier and causing protein leak; NSAIDs restricting renal blood flow and damaging tubules; smoking accelerating atherosclerosis and impairing microvascular circulation including the renal arteries; weight reduction lowering the risk of obesity-related glomerulopathy; and urine albumin detecting glomerular damage long before eGFR declines.

Download the PDF

All source documents